Women and Coronary Artery Disease

Clinical Trial Finder

Many women with coronary artery disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Humidified High Flow Nasal Cannula Versus Nasal Intermittent Positive Ventilation in Neonates

Condition:   Respiratory Insufficiency
Interventions:   Device: NIPPV;   Device: HHFNC
Sponsor:   Gao WeiWei
Not yet recruiting - verified July 2015

Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter

Conditions:   Atrial Fibrillation;   Stroke
Intervention:   Other: Computer Electronic Alert
Sponsors:   Brigham and Women's Hospital;   Daiichi Sankyo Inc.
Not yet recruiting - verified July 2015

GS-4997 in Adults With Pulmonary Arterial Hypertension

Condition:   Pulmonary Arterial Hypertension
Interventions:   Drug: GS-4997;   Drug: Placebo to match GS-4997
Sponsor:   Gilead Sciences
Recruiting - verified July 2015

Absorb IV Randomized Controlled Trial

Conditions:   Coronary Artery Disease;   Coronary Artery Stenosis;   Coronary Disease;   Coronary Stenosis
Interventions:   Device: Absorb BVS;   Device: XIENCE
Sponsor:   Abbott Vascular
Recruiting - verified July 2015

HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt

Conditions:   Coronary Arteriosclerosis;   Non ST Segment Elevation Acute Coronary Syndrome
Interventions:   Device: OrbusNeich Combo stent™;   Device: Everolimus Eluting Stent (EES)
Sponsors:   OrbusNeich;   OrbusNeich Medical K.K.;   Duke Clinical Research Institute
Recruiting - verified July 2015

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia

Condition:   Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
Interventions:   Drug: Epanova® (omega-3 carboxylic acids);   Drug: corn oil control
Sponsors:   AstraZeneca;   The Cleveland Clinic
Recruiting - verified July 2015

Sleep Disordered Breathing, Obesity and Pregnancy Study (SOAP)

Conditions:   Obese;   Pregnancy;   Sleep Disordered Breathing
Interventions:   Device: CPAP;   Device: sham-CPAP
Sponsors:   University of Pittsburgh;   National Heart, Lung, and Blood Institute (NHLBI);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified July 2015

Bardoxolone Methyl Evaluation in Patients With Pulmonary Arterial Hypertension (PAH) - LARIAT

Condition:   Pulmonary Arterial Hypertension
Interventions:   Drug: Bardoxolone methyl;   Drug: Placebo
Sponsor:   Reata Pharmaceuticals, Inc.
Recruiting - verified July 2015

Screening for Abdominal Aortic Aneurysm Using a Portable Transthoracic Echocardiography Among Patients With Acute Coronary Syndrome

Condition:   Acute Coronary Syndrome
Sponsor:   HaEmek Medical Center, Israel
Recruiting - verified July 2015

Beraprost-314d Added-on to Tyvaso® (BEAT)

Condition:   Pulmonary Arterial Hypertension
Interventions:   Drug: Beraprost Sodium 314d Modified Release Tablets;   Drug: Placebo
Sponsor:   Lung Biotechnology PBC
Recruiting - verified July 2015

Intranasal Mometasone in Children With Obstructive Sleep Apnea Due to Adenotonsillar Hypertrophy

Condition:   Obstructive Sleep Apnea (Mild, Moderate, Severe) as Per Polysomnography
Interventions:   Drug: Mometasone furoate nasal spray;   Drug: Placebo
Sponsor:   Children's & Women's Health Centre of British Columbia
Withdrawn - verified July 2015

Get CardioSmart

You're Invited